The Evolving Regulatory Landscape – FDA Approvals and...

added blog Health

2026-04-09 06:22:55 -

The Evolving Regulatory Landscape – FDA Approvals and Expanding Indications

The regulatory pathway for Rituximab Biosimilars Market has matured significantly, with multiple products now approved across major jurisdictions. The U.S. Food and Drug Administration (FDA) has approved several rituximab biosimilars since 2017, including Celltrion’s Truxima, Pfizer’s Ruxience, and Amgen’s Riabni. These approvals have not only validated the...

0 Comments 0 Shares 6 Views 0 Reviews